Jenna Shiels

Jenna Shiels

Auto-generated profile, based on publicly available information

Jenna Shiels

Wellcome‐Wolfson Institute for Experimental Medicine Queen's University Belfast Belfast UK

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2020 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
JSJenna Shiels
Jenna Shiels
Krystyna CwiklinskiKrystyna Cwiklinski
Krystyna Cwiklinski
RARaquel Alvarado
Raquel Alvarado
KTKarine Thivierge
Karine Thivierge
SCSophie Cotton
Sophie Cotton
JDJohn Pius Dalton
John Pius Dalton
Sm16, also known as SPO-1 and SmSLP, is a low molecular weight protein (~16kDa) secreted by the digenean trematode parasite Schistosoma mansoni, one of the main causative agents of human schistosomiasis. The molecule is secreted from the acetabular gland of the cercariae during skin invasion and is believed to perform an immune-suppressive function to protect the invading parasite from innate immune cell attack. We show that Sm16 homologues of the Schistosomatoidea family are phylogenetically related to the helminth defence molecule (HDM) family of immunomodulatory peptides first described in Fasciola hepatica. Interrogation of 69 helminths genomes demonstrates that HDMs are exclusive to trematode species. Structural analyses of Sm16 shows that it consists predominantly of an amphipathic alpha-helix, much like other HDMs. In S. mansoni, Sm16 is highly expressed in the cercariae and eggs but not in adult worms, suggesting that the molecule is of importance not only during skin invasion but also in the pro-inflammatory response to eggs in the liver tissues. Recombinant Sm16 and a synthetic form, Sm16 (34–117), bind to macrophages and are internalised into the endosomal/lysosomal system. Sm16 (34–117) elicited a weak pro-inflammatory response in macrophages in vitro but also suppressed the production of bacterial lipopolysaccharide (LPS)-induced inflammatory cytokines. Evaluation of the transcriptome of human macrophages treated with a synthetic Sm16 (34–117) demonstrates that the peptide exerts significant immunomodulatory effects alone, as well as in the presence of LPS. Pathways most significantly influenced by Sm16 (34–117) were those involving transcription factors peroxisome proliferator-activated receptor (PPAR) and liver X receptors/retinoid X receptor (LXR/RXR) which are intricately involved in regulating the cellular metabolism of macrophages (fatty acid, cholesterol and glucose homeostasis) and are central to inflammatory responses. These results offer new insights into the structure and function of a well-known immunomodulatory molecule, Sm16, and places it within a wider family of trematode-specific small molecule HDM immune-modulators with immuno-biotherapeutic possibilities. Sm16 is a low molecular weight protein (~16kDa) secreted by Schistosoma mansoni, a causative agent of human schistosomiasis. The molecule is secreted by the infectious cercariae during skin invasion and performs an immune-suppressive function to protect the invading parasite from immune attack. Using phylogenetic and gene structure analysis we show that Sm16 homologues of parasites belonging to the Schistosomatoidea superfamily of digenean worms are members of the helminth defence molecule (HDM) family that are potent immune-modulators and exclusive to trematode species. Structural analyses revealed that Sm16, much like other HDMs, consists predominantly of an amphipathic alpha-helix. Sm16 is highly expressed in the cercariae and eggs of S. mansoni but not male or female adult worms, suggesting that the molecule is of importance not only during skin invasion but also in the pro-inflammatory response to eggs in the liver tissues. A synthetic form of the molecule, termed Sm16 (34–117), was shown to bind to and enter immune cells (macrophages) and induce a weak pro-inflammatory response. However, this peptide also blocked the pro-inflammatory effects of bacterial endotoxin (lipopolysaccharide, LPS). Analysis of the transcriptome of Sm16 (34–117)-stimulated macrophages in the presence or absence of LPS suggests that it mediates immunomodulatory activity via signalling pathways that are intricately involved in regulating cellular metabolism (fatty acid, cholesterol and glucose homeostasis) and central to inflammatory responses. These new insights into the structure and function of a well-known immunomodulatory molecule, Sm16, places it within a wider family of trematode-specific small molecule HDM immune-modulators with immuno-biotherapeutic possibilities.

14 February 2025 in The FASEB Journal
Verified
Journal Article
Open access
RLRichard Lalor
Richard Lalor
ATAkane Tanaka
Akane Tanaka
JSJenna Shiels
Jenna Shiels
ADAakanksha Dixit
Aakanksha Dixit
SHSabine Hoadley
Sabine Hoadley
SDSheila Donnelly
Sheila Donnelly
The helminth defense molecules (HDM) are a family of immune regulatory peptides exclusively expressed by trematode worms. We have previously demonstrated that in vivo FhHDM‐1, the archetypal member of the HDMs, regulated macrophage responses to inflammatory ligands, thereby ameliorating the progression of immune‐mediated tissue damage in several murine models of inflammatory disease. Accordingly, we postulated that an understanding of the structure–function relationship of the HDMs would facilitate the identification of the minimal bioactive peptide, which would represent a more synthesizable, cost‐effective, potent biotherapeutic. Thus, using a combination of bioinformatics, structural analyses, and cellular assays we discovered a 40 amino acid peptide derivative termed FhHDM‐1.C2. This peptide contains a 12 amino acid motif at its N‐terminus, which facilitates cellular interaction and uptake, and an amphipathic α‐helix within the C‐terminus, which is necessary for lysosomal vATPase inhibitory activity, with both regions linked by a short unstructured segment. The FhHDM‐1.C2 peptide exhibits enhanced regulation of macrophage function, compared with the full‐length FhHDM‐1, and potent prevention of the progression of relapsing–remitting‐experimental autoimmune encephalomyelitis (EAE) when administered prophylactically or therapeutically. The protective effect of FhHDM‐1.C2 is not associated with global immune suppression, which places the HDMs peptides as an improved class of biotherapeutics for the treatment of inflammatory diseases. Comparing the HDMs from several zoonotic trematodes revealed a similar capacity for immune regulation. These important new advances into the structure–function relationship of the lead HDM peptide, FhHDM‐1, encourage further prospecting and screening of the broader trematode family of peptides for the discovery of novel and potent immune‐biotherapeutics.